search:fda pregnancy category相關網頁資料

瀏覽:1067
日期:2024-05-08
You are here: Home > FDA Pregnancy Categories FDA Pregnancy Categories Category A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters...
瀏覽:877
日期:2024-05-09
CATEGORY DEFINITION COMMENTS A Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities. Drugs that fall under category A have had several well-controlled studies that found no harmful effects or increase...
瀏覽:659
日期:2024-05-06
FDA Drug Safety Communication:Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals D...
瀏覽:1406
日期:2024-05-08
Brief overview of the five pregnancy categories established by the FDA. ... FDA Pregnancy Categories The FDA has established five categories to indicate the potential of a drug to cause birth defects if used during pregnancy....
瀏覽:637
日期:2024-05-03
Additional Information for Patients Taking valproate during pregnancy can decrease your child’s IQ. There is also a higher risk of birth defects if you take valproate during pregnancy. If you are a woman of childbearing age and are taking a valproate prod...
瀏覽:1173
日期:2024-05-09
Includes: definitions of pregnancy drug classifications, how the fda drug classifications are used, the difference between animal and human studies, and risk vs. certainty. ... It's important to be careful what goes in your body during pregnancy and FDA d...
瀏覽:649
日期:2024-05-09
Sometimes use of prescription drugs in pregnancy is unavoidable. Most drugs are generally safe, but a few increase the risk of miscarriage or pregnancy loss. The FDA has developed a category system for prescription drugs to evaluate the risks they pose du...
瀏覽:385
日期:2024-05-05
Pregnancy "Category C" Labeling An FDA Pregnancy Labeling Task Force was organized to review drug labeling information on pregnancy and fetal risks and to explore how the information could be presented to clinicians, reviewers and other interested parties...